mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.032 |
0.3 |
mRNA |
BRD-K34099515 |
CTRPv2 |
pan-cancer |
AAC |
0.07 |
0.3 |
mRNA |
Docetaxel |
CTRPv2 |
pan-cancer |
AAC |
-0.049 |
0.3 |
mRNA |
triptolide |
CTRPv2 |
pan-cancer |
AAC |
-0.033 |
0.3 |
mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.032 |
0.3 |
mRNA |
Bosutinib |
CTRPv2 |
pan-cancer |
AAC |
-0.032 |
0.3 |
mRNA |
blebbistatin |
CTRPv2 |
pan-cancer |
AAC |
-0.067 |
0.3 |
mRNA |
PD-0325901 |
gCSI |
pan-cancer |
AAC |
0.049 |
0.3 |
mRNA |
PF-543 |
CTRPv2 |
pan-cancer |
AAC |
-0.034 |
0.3 |
mRNA |
tandutinib |
CTRPv2 |
pan-cancer |
AAC |
-0.033 |
0.3 |